bendamustine hydrochloride has been researched along with Enlarged Spleen in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Hazim, AZ; Reed, GJ; Sanchez-Alvarez, C; Warrington, KJ | 1 |
| Cerquozzi, S; Liaw, J; Tefferi, A | 1 |
| Adam, Z; Král, Z; Krejčí, M; Mayer, J; Pour, L; Pourová, E; Ševčíková, E; Ševčíková, S | 1 |
1 review(s) available for bendamustine hydrochloride and Enlarged Spleen
| Article | Year |
|---|---|
[Changes in the prognosis and treatment of Waldenström macroglobulinemia. Literature overview and own experience].
Topics: Adenine; Anemia; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Cyclophosphamide; Dexamethasone; Doxorubicin; Humans; Immunoglobulin M; Lenalidomide; Lymphatic Diseases; Neoplasm Recurrence, Local; Piperidines; Prednisone; Prognosis; Pyrazoles; Pyrimidines; Remission Induction; Rituximab; Splenomegaly; Thalidomide; Thrombocytopenia; Vincristine; Waldenstrom Macroglobulinemia | 2016 |
2 other study(ies) available for bendamustine hydrochloride and Enlarged Spleen
| Article | Year |
|---|---|
Type II cryoglobulinemic vasculitis in the setting of MALT lymphoma.
Topics: Acute Kidney Injury; Adrenal Cortex Hormones; Aged; Antineoplastic Agents, Immunological; Bendamustine Hydrochloride; Cryoglobulinemia; Female; Humans; Lymphoma, B-Cell, Marginal Zone; Rituximab; Splenomegaly; Vasculitis | 2021 |
Bendamustine therapy associated resolution of anemia and splenomegaly in myelofibrosis.
Topics: Anemia; Antineoplastic Agents, Alkylating; Bendamustine Hydrochloride; Humans; Male; Middle Aged; Splenomegaly; Thrombocythemia, Essential; Treatment Outcome | 2016 |